IRCT20111119008129N12招募中3 期
The protective Potential of resveratrol in the prevention and reduction of complications in patients undergoing elective coronary artery bypass grafting surgery
Boushehr University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 70 years（—）
- 性别
- All
入选标准
- •Intention of the patients to participate in the trial
- •Patients on elective surgery
- •Having no addiction to any drugs or alcohol
- •Not having mental or psychological disorders
- •Participants with the age between 30 to 70 years
排除标准
- •History of having chronic kidney disease,
- •History of having chronic liver disease
- •Having heart surgery before
研究者
相似试验
招募中
3 期
Resveratrol in COVID19IRCT20200112046089N1Ahvaz University of Medical Sciences50
已完成
3 期
Investigating the effect of resveratrol on polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovary syndromeE28.2IRCT20221106056417N1Tehran University of Medical Sciences56
招募中
3 期
The effect of Resveratrol on some biochemical and hormonal factorsMetabolic syndrome.IRCT20200408046987N4Qazvin University of Medical Sciences80
已完成
3 期
Evaluation of the effects of resveratrol in patients with Covid ??Covid-19.COVID-19, virus identifiedIRCT20111119008129N13Boushehr University of Medical Sciences140
已完成
不适用
The effects of Resveratrol on PCOS.Polycystic ovarian syndrome (PCOS).Polycystic ovarian syndromeIRCT2016030126860N1Tehran University of Medical Sciences40